| Position | Action |
|---|---|
| Tranche 1 (current levels) | 30% of target weight, 2.5% book cap |
| Tranche 2: 50 SMA retest hold OR Bollinger upper band close >$183 | Deploy Tranche 2 |
| Tranche 3: 200 SMA reclaim at $205.84 on ≥7M volume | Deploy Tranche 3 |
| September earnings: material bookings disappointment | Halve all tranches and re-evaluate |
ACN at $175 is a mispriced opportunity in a post-capitulation recovery, not a value trap; the stock offers double-digit FCF yields and capital returns while AI expands its total addressable market through enterprise transformation mandates.
| Indicator | Value | Signal |
|---|---|---|
| Close | $175.72 | bullish |
| RSI (14) | 68.12 | bullish |
| MACD (12,26,9) | 7.48 | bullish |
| MACD Signal | 4.65 | bullish |
| MACD Histogram | 2.83 | bullish |
| 10 EMA | $165.94 | bullish |
| 50 SMA | $152.62 | bullish |
| 200 SMA | $205.84 | bearish |
| Bollinger Middle (20 SMA) | $154.23 | neutral |
| Bollinger Upper Band | $183.24 | neutral |
| Bollinger Lower Band | $125.22 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Initiate Overweight in ACN with staged tranches and hard $156 stop
The position offers asymmetric risk-reward: bounded downside via $156 stop (11% from entry, 3.4% above 50 SMA), staged upside via two confirmation-gated tranches, and real-time income from the 3.81% dividend yield. The September earnings checkpoint prevents emotional decision-making during binary outcomes while the 200 SMA at $205.84 represents both the entry target for Tranche 3 and a wall of overhead supply from underwater institutional holders that must be absorbed. The three-tranche structure with hard catalyst checkpoint balances the aggressive view (chasing confirmed breakout) against the conservative view (gap risk and mixed AI thesis) via SPCX/CRM/MSFT framework lessons.
When: 50 SMA retest hold OR Bollinger upper band close >$183
Then: Scale in Tranche 2
Multiple compression to 14x P/E represents market mispricing of a high-quality compounder
↩ rebuts: “Bear's claim that multiple compression signals permanent growth impairment”
· concedes: Bear correctly identifies technical weakness (below 200 SMA); Bear correctly identifies multiple compression from historical norms; Bear correctly flags goodwill as a占总资产 37% concern; Q2 FY26 was soft — consistent with historical IT services seasonality
ACN at $175 is a value trap dressed as a recovery opportunity — the long-term downtrend is intact, volume is fading into resistance, multiple independent sources confirm bookings deterioration, AI revenue remains unproven, and the capital return program is masking reinvestment starvation, creating asymmetric risk to the June 30 low of $122.96.
· concedes: ACN has elite fundamentals: 24% ROE, $12B in FCF; Value opportunity would exist at lower prices with confirmed 200 SMA reclaim ($205.84) and volume base
→ vs conservative: 200 SMA breakdown at $205.84 is not a bear market signal but a re-rating event; current 14x earnings vs historical 22-28x means market has already priced in structural pessimism, so reclaiming the 200 SMA will happen faster than expected and at worse entry prices
→ vs conservative: Stop at $152 (2.9x ATR) is appropriate for a confirmed recovery regime after black swan capitulation; tighter stops would result in being shaken out at the bottom and missing the rally
→ vs conservative: Volume divergence concern misreads recent lighter volume (5.2M and 3.4M shares) as distribution; structural move was confirmed on heavier volume sessions, and VWMA at $159 confirms rally is volume-supported
→ vs neutral: Value trap narrative is wrong; 24% ROE, 11.2% FCF yield, $8.3B capital returns, 13% deferred revenue growth prove business is not impaired, just sentiment overhang
→ vs neutral: Waiting for bookings stabilization means waiting for confirmation that value is recognized, which by definition means waiting for worse entry prices
→ vs neutral: AI ROI concern (fewer C-suite leaders reporting tangible AI value) describes the opportunity, not threat; clients cannot extract value from AI pilots alone, so they need Accenture, explaining continued deal flow
| neutral |
| ATR (14) | $8.34 | — |
| VWMA | $159.01 | bullish |
Support: 165.94 · 152.62 · 125.22 | Resistance: 183.24 · 205.84 · 230 · 240
ACN is in a post-crash recovery rally following a June 18 capitulation event (-17.96%, volume spike to 41.7M). Short-term trend is bullish with price trading +9.8% above the 10 EMA and RSI confirming momentum without overbought exhaustion. Medium-term recovery is confirmed with price clearing the 50 SMA. Long-term trend remains bearish with the 200 SMA at $205.84 representing the critical level that must be reclaimed to confirm a true regime change. Resistance sits at $183.24 (upper Bollinger) and $205.84 (200 SMA); support at $165.94 (10 EMA), $152.62 (50 SMA), and $125.22 (lower Bollinger).
Market Cap
$107.5B
P/E (TTM)
14.02
Forward P/E
11.97
PEG Ratio
1.24
P/B
3.37
EPS (TTM)
$12.53
Forward EPS
$14.68
Dividend Yield
3.81%
Beta
1.07
52-Week Range
$118.15 – $291.09
50-Day MA
$154.10
200-Day MA
$210.63
TTM Revenue
$73.1B
TTM Net Income
$7.79B
FY2025 Revenue
$69,673M
FY2025 Revenue Growth
+7.4%
FY2025 Gross Profit
$22,235M
FY2025 Gross Margin
31.9%
FY2025 Operating Income
$10,841M
FY2025 Operating Margin
15.6%
FY2025 Net Income
$7,678M
FY2025 Diluted EPS
$12.15
FY2025 Special Charges
$615M
FY2025 D&A
$1,368M
Gross Margin (TTM)
32.0%
Operating Margin (TTM)
17.0%
Net Profit Margin
10.7%
ROE
24.4%
ROA
10.9%
EBITDA Margin
17.7%
TTM Operating Cash Flow
~$13.2B
TTM Free Cash Flow
$12.1B
FY2025 Operating Cash Flow
$11,474M
FY2025 CapEx
$600M
FY2025 Free Cash Flow
$10,874M
FCF / Net Income
~155%
FY2025 Dividends Paid
$3,700M
FY2025 Buybacks
$4,619M
Total Assets
$68,807M
Cash & Equivalents
$10,165M
Goodwill
$25,323M
Total Liabilities
$35,299M
Long-Term Debt
$5,029M
Total Equity
$33,508M
Working Capital
$7,329M
Current Ratio
1.34
D/E (true)
0.26
Net Cash Position
~$1.8B
Diluted Share Count
615.6M
Deferred Revenue
$7.57B
Receivables
$16,036M
FCF Yield (TTM)
~11.2%
Capital Return / FCF
~77%
Strengths
Concerns
Accenture presents a compelling value opportunity with best-in-class fundamentals including 24% ROE, $12B TTM FCF, and 32% gross margins, yet trades at a P/E of ~14 (vs historical 22-28) amid 50%+ drawdown from highs. The company operates a capital-light services model generating ~10% FCF yield and returns substantial capital through $8.3B annually in dividends and buybacks. While AI disruption concerns and heavy goodwill ($25B) warrant monitoring, Q3 FY26 showed re-acceleration with +5.6% revenue growth and deferred revenue +13% YoY signals healthy bookings. HOLD with bias toward BUY on weakness for long-term investors.